Φορτώνει......
Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities
PURPOSE: Although a significant number of reports on new therapeutic options for refractory Kawasaki disease (KD) such as steroid, infliximab, or repeated intravenous immunoglobulin (IVIG) are available, their effectiveness in reducing the prevalence of coronary artery lesions (CAL) remains controve...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Korean J Pediatr |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
The Korean Pediatric Society
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5014912/ https://ncbi.nlm.nih.gov/pubmed/27610181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3345/kjp.2016.59.8.328 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|